Search results for "Diabetes"


 
Results 41 - 50 of about 886 for "Diabetes".

New drugs approved for type 2 diabetes and COPD | ACP Internist

This regulatory update covers dapaglifozin (Farxiga) a sodium-glucose co-transporter 2 inhibitor, to treat diabetes, and umeclidinium and vilanterol inhalation (Anoro Ellipta) for maintenance of chronic obstructive pulmonary disease.

Reconciling conflicting diabetes guidance | ACP Internist

ACP and other professional medical societies disagree on a proper target for the long-term benefits of glucose control.

Weight-loss surgery more effective for diabetes than medication : ACP Internist

About 20 million Americans currently have type 2 diabetes, three times more than in 1980. Diabetes is a major risk factor for stroke and hea...

More compounded products recalled, diabetes drug approved | ACP Internist

This regulatory update covers a recall of a compounding pharmacy's products due to mold and approval of a sodium-glucose co-transporter for diabetes.

QD: News Every Day--Waist circumference more strongly associated with diabetes risk : ACP Internist

The evidence of an association between women with big waists and the onset of diabetes got a little bit more solid, thanks to a study of mor...

New diabetes drug, LABA for COPD, skin antibiotic approved | ACP Internist

This update covers approval of a sodium-glucose co-transporter 2 inhibitor for diabetes, a once-daily long-acting beta-adrenergic agonist (LABA) for chronic obstructive pulmonary disease (COPD), and a new intravenous drug for bacterial skin and

Experts offer advice on oral drugs, insulin for diabetes | ACP Internist

Any type 2 diabetic is eventually going to need oral medications, and some on oral medications may eventually progress to needing insulin. The regimens are complex and vary from patient to patient. Learn how to individually tailor such decisions.

QD: News Every Day--Primary care doctors more proactive with diabetes care : ACP Internist

Regular primary care providers treat diabetic patients more proactively than covering physicians or midlevel providers, shown by an increase...

Warning on an antipsychotic; generic rosuvastatin approval | ACP Internist

This update covers new warnings on the entire class of opioids and approval of the first leadless pacemaker approved to treat heart rhythm disorders.

Changing thinking on chronic fatigue | ACP Internist

A recent report might shed some diagnostic insight on the profound fatigue, unrefreshing sleep, and other nagging symptoms that could indicate myalgic encephalomyelitis/chronic fatigue syndrome.

Prev   1   2   3   4   5   6   7   8   9   10   Next